Table 1 Comparison of cases with endometrioid carcinoma and proliferative endometrium
From: Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma
| Â | IHS score | Endometrioid | Proliferative | P value |
|---|---|---|---|---|
carcinoma | endometrium | |||
(n = 47) | (n = 10) | |||
Fascin | 0 | 13 (27.7%) | 7 (70.0%) | p = 0.023 |
≤10 | 27 (57.4%) | 3 (30.0%) | ||
≥11 | 7 (14.2%) | 0 (0%) | ||
CD44v6 | 0 | 25 (53.2%) | 6 (60.0%) | p = 0.542 |
≤10 | 19 (40.4%) | 4 (40%) | ||
≥11 | 3 (6.4%) | 0 (0%) |